Targeted News Service

Agilent NovoCyte Opteon Wins 'Best New Drug Discovery & Development Product of 2024' Award
January 30, 2025

SANTA CLARA, California, Jan. 30 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:

* * *

Agilent NovoCyte Opteon Wins 'Best New Drug Discovery & Development Product of 2024' Award

SANTA CLARA, Calif., January 29, 2025

Agilent Technologies Inc. (NYSE: A) is pleased to announce that the Agilent NovoCyte Opteon Spectral Flow Cytometer has . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form